DNA ploidy patterns in gastric adenocarcinoma

Journal of Korean Medical Science

Volumn 15, Issue 2, 2000, Pages 159-166

  Kim, Jung Yeon ^a   Cho, Hye Jae ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Ki 67 Antigen; Ploidies; Stomach Neoplasms

Indexed keywords

KI 67 ANTIGEN;

ADENOCARCINOMA; AGED; ANEUPLOIDY; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CHEMISTRY; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; AGED; ANEUPLOIDY; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; FLOW CYTOMETRY; GASTRIC MUCOSA; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 0034170084     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2000.15.2.159     Document Type: Article

References (46)

1. Spiessl B, Beahrs OH, Hermanek P, Hutter RV, Scheibe O, Sobin LH, Wagner G. UICC International Union Against Cancer TNM atlas, illustrated guide to the TNM/pTNM classification of malignant tumors. Springer, Berlin Heidelberg New York: 1989; 71-81.
2. Santini D, Bazzocchi F, Mazzoleni G, Ricci M, Viti G, Marrano D, Martinelli G. Signet ring cells in advanced gastric cancer. Acta Pathol Microbiol Immunol Scand [A] 1987; 95: 225-31.
3. Friedlander M, Hedley DW, Taylor IW, Rugg CA, Musgrove A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Clin Pathol 1984; 37: 961-74.
4. Wersto R, Liblit RL, Deitch D, Koss LG. Variability in DNA measurements in multiple tumor samples of human colonic carcinoma. Cancer 1991; 67: 106-15.
5. Lee JS, Cheon KS, Park CS. The study of p53 expression and DNA ploidy in colorectal carcinoma. Korean J Pathol 1996; 30: 775-83.
6. Macartney J, Camplejohn R, Powell G. DNA flowcytometry of histological material from human gastric cancer. J Pathol 1986; 148: 273-7.
7. Yonemura Y, Ohyama S, Sugiyama K, Kamata T, De Aretxabala X, Kimura H, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I. Retrospective analysis of the prognostic significance of DNA ploidy patterns and s-phase fraction in gastric carcinoma. Cancer Res 1990; 50: 509-14.
8. Ming SC, Goldman H, Freiman DC. Intestinal metaplasia and histogenesis of carcinoma in human stomach; light and electron microscopic study. Cancer 1976; 20: 1418-29.
9. Kim JS, Choi CW, Kim BS, Shin SW, Kim YH, Mok YJ, Kim JS, Koo BH. Amplification of c-erbB-2 proto-oncogene in cancer foci, adjacent normal, metastatic and normal tissue of human primary gastric adenocarcinomas. J Korean Med Sci 1997; 12: 311-5.
10. Slaughter EP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6: 963-8.
11. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993; 7: 139-46.
12. De Aretxabala X, Yonemura Y, Sugiyama K, Hirose N, Kumaki T, Fushida S, Miwa K, Miyazaki I. Gastric cancer heterogeneity. Cancer 1989; 63: 791-8.
13. Umehara Y, Kimura T, Yoshida M, Oba N, Harada Y. Metastatic node of gastric carcinoma by flow cytometrical and clinicopathologic parameters. Clin Exp Metas 1992; 10: 19-24.
14. Umehara Y, Kimura T, Yoshida M, Oba N, Harada Y. Comparison of flow cytometric DNA content in primary gastric carcinoma and metastases. J Surg Oncol 1992; 50: 156-60.
15. Flyger HL, Christensen IJ, Thorup J, Hakansson TU, Norgaard T. DNA aneuploidy in gastric carcinoma: flow cytometric data related to survival, location, and histopathologic findings. Scand J Gastroenterol 1995; 30: 258-64.
16. Yonemura Y, Matsumoto H, Ninomiya I, Ohyama S, Kimura H, de Aletxabala X, Sugiyama K, Kamata T, Kinoshita K, Fushida S. Heterogeneity of DNA ploidy in gastric cancer. Anal Cell Pathol 1992; 4: 61-7.
17. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
18. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990; 17: 489-503.
19. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 1996; 53: 182-91.
20. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer. Anticancer Res 1997; 17: 2923-6.
21. Cotran RS, Kumar VK, Collins T. Robbins pathologic basis of disease. 6th ed Philadelphia: WB Saunders, 1999; 800-1.
22. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. A method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Hsitochem Cytochem 1983; 31: 1333-5.
23. Santoro E, Carboni M, Catarci M, Carlini M, Carboni F, Zupi G, Vecchione A, D'Agnano I, Giannarelli D, Santoro R, Garofalo A. DNA ploidy, proliferate index and EGF-R status in 130 cases of resected gastric cancer - a multivariate analysis. Hepatogastroenterology 1997; 44: 826-37.
24. Kimura H, Yonemura Y. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis. Cancer 1991; 67: 2588-93.
25. Filipe MI, Rosa J, Sandey A, Imrie PR, Ormerod MG, Morris RW. Is DNA ploidy and proliferate activity of prognostic value in advanced gastric carcinoma? Hum Pathol 1991; 22: 373-8.
26. Inokuchi K, Kodama Y, Sasaki O, Kamegawa T, Okamura T. Differentiation and growth patterns of early gastric carcinoma determined by cytophotometric DNA analysis. Cancer 1983; 51: 1138-41.
27. Johnson H, Belluco C, Masood S, Abou-Azama AM, Kahn L, Wise L. The value of flow cytometric analysis in patients with gastric cancer. Arch Surg 1993; 128: 314-7.
28. Baretton G, Carstensen O, Schardey M, Lohrs U. DNA-ploidy and survival in gastric carcinomas: a flow-cytometric study. Virchows Arch [Pathol Anat] 1991; 418: 301-9.
29. Czerniak B, Herz F, Koss LG. DNA distribution patterns in early gastric carcinomas: a Feulgen cytometric study of gastric brush smears. Cancer 1987; 59: 113-7.
30. Yang YI, Joo JE. Prognostic implications of DNA ploidy and S-phase fraction comparing with other prognostic factors in advanced colorectal adenocarcinomas. Korean J Pathol 1995; 29: 170-80.
31. Korenaga D, Haraguchi M, Okamura T, Baba H, Saito A, Sugimachi K. DNA ploidy and tumor invasion in human gastric cancer. Arch Surg 1989; 124: 314-8.
32. Wyatt JI, Quirke P, Ward DC, Clayden AD, Dixon MF, Johnston D, Bird CC. Comparison of histopathological and flow cytometric parameters in prediction of prognosis in gastric cancer. J Pathol 1989; 158: 195-201.
33. Sasaki K, Takahashi M, Hashimoto T, Kawachnino K. Flow cytometric DNA measurements of gastric cancers, clinicopathological implication of DNA ploidy. Pathol Res Pract 1989; 184: 561-6.
34. Oh YL, Han J, Ko YH, Park CK, Ree HJ. Correlation betwen p53 immunohistochemical expression, DNA ploidy and Ki-67 expression in gastric carcinoma. Korean J Pathol 1997; 31: 1264-71.
35. Hattori T, Hosokawa Y, Sugihara H, Fukuda M. DNA content of diffusely infiltrative carcinomas in the stomach. Pathol Res Pract 1985; 180: 615-8.
36. Haraguchi M, Okamura T, Korenaga D, Tsujitani S, Marin P, Sugimachi K. Heterogeneity of DNA ploidy in patients with undifferentiated carcinomas of the stomach Cancer 1987; 59: 922-4.
37. Sugihara H, Hattori T, Fujita S, Hirose K, Fukuda M. Regional ploidy variations in signet ring cell carcinomas of the stomach. Cancer 1990; 65; 122-9.
38. Sasaki K, Hashimoto T, Kawachino K, Takahashi M. Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas. Cancer 1988; 62: 2569-75.
39. Dodd LG, Kerns BJ, Dodge RK, Layfield LJ. Intratumoral heterogeneity in primary breast carcinoma: Study of concurrent parameters. J Surg Oncol 1997; 64: 280-8.
40. Sasaki K, Murakami T, Kawasaki M, Takahashi M. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J Cell Physiol 1987; 133: 579-84.
41. Shikhani AH, Matanoski GM, Jones MM, Kashima HK, Johns MT. Multiple primary malignancies in head and neck cancer. Arch Otolaryngol Head Neck Surg 1986; 112: 1172-9.
42. Califano J, Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D. Genetic progression model for head and neck cancer: implication for field cancerization. Cancer Res 1996; 56: 2488-92.
43. Tsujino T, Yoshida K, Nakayama H, Ito H, Shimosato T, Tahara E. Alterations of oncogenes in metastatic tumors of human gastric carcinomas. Br J Cancer 1990; 62: 226-30.
44. Mizutani T, Onda M, Tokunaga A, Yamanaka N, Sugisaki Y. Relationship of c-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 1993; 72: 2083-8.
45. Ohyama S, Yonemura Y, Miyazaki I. Proliferate activity and malignancy in human gastric cancers: significance of the proliferation rate and its clinical application. Cancer 1992; 69: 314-21.
46. Yonemura Y, Kimura H, Ohoyama S, Kamata T, Yamaguchi A, Matsumoto H, Ninomiya I, Miyazaki I. Immunohistochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67. Oncology 1991; 48: 589-93.